Journal article

Advances and Unmet Needs in the Therapeutics of Bone Fragility

Sabashini K Ramchand, Ego Seeman

Frontiers in Endocrinology | FRONTIERS MEDIA SA | Published : 2018


The prevalence of fragility fractures increases as longevity increases the proportion of the elderly in the community. Until recently, the majority of studies have targeted women with osteoporosis defined as a bone mineral density (BMD) T score of < -2.5 SD, despite evidence that the population burden of fractures arises from women with osteopenia. Antiresorptive agents reduce vertebral and hip fracture risk by ~50 percent during 3 years but efficacy against non-vertebral fractures, 80% of all fractures in the community, is reported in few studies, and of those, the risk reduction is only 20-30%. Recent advances in the use of antiresorptives and anabolic agents has addressed some of these un..

View full abstract

University of Melbourne Researchers